Compounds having a protective activity against toxins with intracellular activity
US-9540356-B2 · Jan 10, 2017 · US
2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections
US9675615B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9675615-B2 |
| Application number | US-201314436390-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 18, 2013 |
| Priority date | Oct 19, 2012 |
| Publication date | Jun 13, 2017 |
| Grant date | Jun 13, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Use of 2,3-dihydroquinazolin-4(1H)-one cyclic derivatives of formula (I) for the treatment of infection with viruses entering cells by endocytosis, especially filovirus such as Ebolavirus.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating a viral infection in a subject where the virus is a filovirus or an adenovirus, the method comprising administering to the subject a therapeutically effective amount of a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein: R 1 is a hydrogen atom, a halogen atom or a C 1 -C 3 alkoxy g…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
- A61K31/517Primary
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9675615B2 cover?
- Use of 2,3-dihydroquinazolin-4(1H)-one cyclic derivatives of formula (I) for the treatment of infection with viruses entering cells by endocytosis, especially filovirus such as Ebolavirus.
- Who is the assignee on this patent?
- Commissariat Energie Atomique, Univ Of Texas Medical Branch, Univ Texas
- What technology area does this patent fall under?
- Primary CPC classification A61K31/517. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).